Head and Neck Diseases by Alexandros G.Sfakianakis: Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059.

Παρασκευή 19 Ιανουαρίου 2018

Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059.

https:--www.ncbi.nlm.nih.gov-corehtml-pm

Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059.

Blood. 2017 05 18;129(20):2808-2810

Authors: Walter HS, Jayne S, Rule SA, Cartron G, Morschhauser F, Macip S, Karlin L, Jones C, Herbaux C, Quittet P, Shah N, Hutchinson CV, Fegan C, Yang Y, Mitra S, Salles G, Dyer MJS

PMID: 28377400 [PubMed - indexed for MEDLINE]

http://ift.tt/2rrrVjB

Head and Neck Diseases by Alexandros G.Sfakianakis

Παρασκευή 19 Ιανουαρίου 2018

Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059.

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου